CAS RN: 2131191-71-2
Methyl 5-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2131191-71-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2131191-71-2 / methyl 5-bromo-3,4-dihydro-2H-1,4-benzoxazine-7-carboxylate
Standard CAS: 2131191-71-2
Multi CAS: No
Basic Information
copy
CAS
2131191-71-2 copy
Multi CAS
No copy
Molecular Formula
C10H10BrNO3 copy
Molecular Weight
272.090000 copy
Exact Mass
270.984410 copy
SMILES
COC(=O)C1=CC2=C(C(=C1)Br)NCCO2 copy
InChI
InChI=1S/C10H10BrNO3/c1-14-10(13)6-4-7(11)9-8(5-6)15-3-2-12-9/h4-5,12H,2-3H2,1H3 copy
InChIKey
OVEBATCVBDTIHN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.3 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
59.47 copy
TPSA
47.56 copy
LogP / Solubility
WLOGP
2.04 copy
MLOGP
1.8 copy
XLogP3
2.2 copy
Consensus LogP
2.01 copy
Log S (ESOL)
-3.04 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.26 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.24 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.93 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy